HomeITRM • NASDAQ
add
Iterum Therapeutics PLC
Previous close
$0.99
Day range
$0.97 - $1.03
Year range
$0.81 - $3.02
Market cap
39.70M USD
Avg Volume
552.89K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.37M | -45.35% |
Net income | -4.89M | 31.12% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.64M | 40.89% |
Effective tax rate | -1.24% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.65M | -30.54% |
Total assets | 32.98M | 68.03% |
Total liabilities | 35.53M | 37.84% |
Total equity | -2.55M | — |
Shares outstanding | 34.06M | — |
Price to book | -14.09 | — |
Return on assets | -23.91% | — |
Return on capital | -26.13% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.89M | 31.12% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2015
Website
Employees
9
